Actively Recruiting
Study of NeuroTrainer Virtual Reality Cognitive Training to Improve Attention and Executive Function in Students With ADHD or Attention Difficulties Aged 11 to 17
Led by NeuroTrainer · Updated on 2025-06-19
155
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the feasibility and effectiveness of NeuroTrainer cognitive training to improve attention and executive control functions in students aged 11 to 17, including those with and without attention-related difficulties such as ADHD. The study aims to determine if NeuroTrainer can improve these cognitive functions, engage targets related to ADHD inattention symptoms, and transfer skills to improve academic behaviors. Participants with various ADHD types and severity levels are included. The study compares two groups one using the NeuroTrainer VR-based cognitive training program and a control group receiving standard educational interventions. The NeuroTrainer group participates in 30-minute virtual reality sessions combining physical activity and cognitive tasks about three times a week for 12 weeks. The control group continues with regular classroom instruction and academic tasks without additional cognitive training. Participants will undergo assessments at Week 1, Month 2, Month 3, and Month 9 using several NIH Toolbox cognitive tests measuring attention, inhibitory control, working memory, and processing speed. Additional evaluations include ADHD symptom scales and academic performance ratings. The study uses random assignment to groups and single masking, with a total follow-up of at least 9 months to monitor changes and maintenance of cognitive and academic improvements.
CONDITIONS
Brief Title
NeuroTrainer Cognitive Training For Academic Focus
Research Team
J
Jeff Nyquist, Ph.D.
J
Julie Schweitzer, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here